Clinical trial
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
NCT00283322 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00283322 |
|---|---|
| Title | Heparin Antibodies in Intensive Care Unit Patients (HAICU) |
| Official title | Heparin Antibodies in Intensive Care Unit Patients (HAICU) |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Heparin-Induced Thrombocytopenia |
| Intervention type | Other |
| Interventions | blood samples (2) |
| Enrollment | 185 |
| Start date | Nov 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Jan 27, 2006 |
| Last update posted | Dec 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: